On the performances of Intensity Modulated Protons, RapidArc and Helical Tomotherapy for selected paediatric cases
Creators
- 1. Oncology Institute of Southern Switzerland, Medical Physics Unit, Bellinzona (Switzerland)
- 2. London Regional Cancer Program, London Health Sciences Centre, London, Ontario (Canada)
- 3. Ospedale Regionale Bellinzona e Valli, Radiology Dept, Bellinzona (Switzerland)
Description
To evaluate the performance of three different advanced treatment techniques on a group of complex paediatric cancer cases. CT images and volumes of interest of five patients were used to design plans for Helical Tomotherapy (HT), RapidArc (RA) and Intensity Modulated Proton therapy (IMP). The tumour types were: extraosseous, intrathoracic Ewing Sarcoma; mediastinal Rhabdomyosarcoma; metastastis of base of skull with bone, para-nasal and left eye infiltration from Nephroblastoma of right kidney; metastatic Rhabdomyosarcoma of the anus; Wilm's tumour of the left kidney with multiple liver metastases. Cases were selected for their complexity regardless the treatment intent and stage. Prescribed doses ranged from 18 to 53.2 Gy, with four cases planned using a Simultaneous Integrated Boost strategy. Results were analysed in terms of dose distributions and dose volume histograms. For all patients, IMP plans lead to superior sparing of organs at risk and normal healthy tissue, where in particular the integral dose is halved with respect to photon techniques. In terms of conformity and of spillage of high doses outside targets (external index (EI)), all three techniques were comparable; CI90% ranged from 1.0 to 2.3 and EI from 0 to 5%. Concerning target homogeneity, IMP showed a variance (D5%–D95%) measured on the inner target volume (highest dose prescription) ranging from 5.9 to 13.3%, RA from 5.3 to 11.8%, and HT from 4.0 to 12.2%. The range of minimum significant dose to the same target was: (72.2%, 89.9%) for IMP, (86.7%, 94.1%) for RA, and (79.4%, 94.8%) for HT. Similarly, for maximum significant doses: (103.8%, 109.4%) for IMP, (103.2%, 107.4%) for RA, and (102.4%, 117.2%) for HT. Treatment times (beam-on time) ranged from 123 to 129 s for RA and from 146 to 387 s for HT. Five complex pediatric cases were selected as representative examples to compare three advanced radiation delivery techniques. While differences were noted in the metrics examined, all three techniques provided satisfactory conformal avoidance and conformation
Availability note (English)
Available from http://dx.doi.org/10.1186/1748-717X-4-2; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672932Additional details
Identifiers
Publishing Information
- Journal Title
- Radiation Oncology (Online)
- Journal Volume
- 4
- Journal Page Range
- p. 2
- ISSN
- 1748-717X
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 47029339
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ANIMAL TISSUES; CAT SCANNING; CT-GUIDED RADIOTHERAPY; INDEXES; INTEGRAL DOSES; KIDNEYS; METASTASES; PATIENTS; PEDIATRICS; PERFORMANCE; PROTONS; RADIATION DOSE DISTRIBUTIONS; SARCOMAS
- Descriptors DEC
- BARYONS; BODY; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DISEASES; DOCUMENT TYPES; DOSES; ELEMENTARY PARTICLES; FERMIONS; HADRONS; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; NUCLEONS; ORGANS; RADIATION DOSES; RADIOLOGY; RADIOTHERAPY; THERAPY; TOMOGRAPHY
Optional Information
- Copyright
- Copyright (c) 2009 Fogliata et al
- Notes
- PMCID: PMC2672932; PUBLISHER-ID: 1748-717X-4-2; PMID: 19144155; OAI: oai:pubmedcentral.nih.gov:2672932; licensee BioMed Central Ltd.